Skip to main content
L

Liven

Liven provides a digital therapeutic program to improve blood glucose control for Type 2 Diabetes patients. The 12-week personalized plan combines self-management education and behavior change coaching, accessible via a mobile app for patients and a dashboard for clinicians.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Individuals diagnosed with Type 2 Diabetes often lack access to comprehensive educational programs and consistent support for self-management. This gap in care contributes to suboptimal blood glucose control, increased healthcare expenditures, and reduced quality of life for affected patients.

Solution

Liven offers a clinically validated digital therapeutic program designed to improve blood glucose control for Type 2 Diabetes patients. The program integrates a 12-week personalized care plan featuring self-management education materials and behavior change coaching. Patients utilize a mobile application for logging lifestyle data, receiving continuous support, and booking appointments, while clinicians leverage a dashboard to monitor patient progress, communicate directly, and set personalized goals. This approach aims to enhance patient engagement with their care providers and deliver a more cost-effective solution for managing diabetes.

Target Audience

The primary users are adults diagnosed with Type 2 Diabetes seeking to improve their blood glucose control and self-management capabilities. The solution also targets healthcare systems and government entities looking for cost-effective diabetes management tools.

Features

  • 12-week personalized care plan with tailored self-management education materials.
  • Cognitive-behavioral coaching focused on lifestyle modification for diabetes management.
  • Mobile application for comprehensive lifestyle logging, continuous support, and appointment booking.
  • Clinician dashboard for real-time patient data review, direct communication, and goal setting.
  • Evidence-based digital therapeutic program designed to improve blood glucose levels.
  • Meal review and advice functionality within the patient application.
This profile is AI-generated and may contain inaccuracies.